Zurich Cantonal Bank
SLXP

Zurich Cantonal Bank’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Zurich Cantonal Bank’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,134
Closed -$1.06M – 2180
2015
Q1 		$1.06M Hold
6,134
– – 0.01% 682
2014
Q4 		$705K Buy
+6,134
New +$743K 0.02% 613
2014
Q3 		– Sell
-81,640
Closed -$10.1M – 1016
2014
Q2 		$10.1M Buy
81,640
+960
+1% +$106K 0.3% 74
2014
Q1 		$8.36M Sell
80,680
-3,200
-4% -$328K 0.26% 81
2013
Q4 		$7.54M Sell
83,880
-102,640
-55% -$8.19M 0.25% 87
2013
Q3 		$12.5M Buy
186,520
+58,630
+46% +$4.04M 0.43% 42
2013
Q2 		$8.46M Buy
+127,890
New +$7.31M 0.3% 77

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Zurich Cantonal Bank's SLXP Position: Q2 2015 in Review

Zurich Cantonal Bank sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 6,134 shares — an estimated $1.06M sold.

Zurich Cantonal Bank first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $12.5M in Q3 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Zurich Cantonal Bank reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Zurich Cantonal Bank sold 6,134 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $1.06M.
  • Zurich Cantonal Bank first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
  • Zurich Cantonal Bank's SALIX PHARMACEUTICALS LTD DEL position peaked at $12.5M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Zurich Cantonal Bank's 13F filing for Q2 2015, filed 11 Aug 2015.